Table 3. In Vitro Data for Compound 14 (Containing a N-Methylpiperazine Moiety) and Compound 20 (Containing a Morpholine Ring).
compd | heps(r) CLblood (L/h/kg), Fmax (%)a | Caco-2 Papp A–B (nm/s), efflux ratio | CYP inhibition IC50 (μM) | CYP induction NOEL (μg/L) |
---|---|---|---|---|
14 | 2.62, 38 | 102, 1.0 | 3A4, 1A2, 2C8, 2C9, 2D6 > 20 | 1A2 = 7; 3A4 = 1667 |
20 | 0.26, 94 | 190, 0.5 | 3A4, 1A2, 2C8, 2C9, 2D6 > 10 | 1A2 = 3333; 3A4 = 3333 |
In vitro stability in rat hepatocytes (heps(r)). Fmax: calculated maximal oral availability.